Avilar Therapeutics
Pioneering the discovery and development of extracellular protein degraders.
25 employees · est. 2020 · Waltham, United States
ProFound Therapeutics
Pioneering the expanded human proteome to reveal a universe of new medicines.
51 employees · est. 2022
Avilar Therapeutics is the older company (2020 vs 2022); ProFound Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Avilar Therapeutics | ProFound Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2020 older | 2022 |
| Headquarters | ||
| Headquarters | Waltham, United States | Not tracked yet |
| Employees | ||
| Employees | 25 | 51 larger |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Seed | Unknown |
| Total Funding | ||
| Total Funding | $75.00M | $75.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 1 |
| Services | ||
| Services | Development of novel protein degraders, Utilization of the endolysosome for protein degradation, Design and assembly of ATACs for extracellular proteins | Expanded Human Proteome Analysis, Novel Protein Identification, Therapeutic Development Platforms |
| Target Customers | ||
| Target Customers | Healthcare Providers, Pharmaceutical Companies, Biotechnology Researchers, Drug Development Organizations | Biopharmaceutical Companies, Research Institutions, Healthcare Providers, Biotech Researchers |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Extracellular Protein Degraders, Targeted Protein Degradation, ASGPR Targeting Chimeras, ATAC Platform, Protein Degrader Therapeutics, Disease-Causing Proteins, Endolysosome, Small Molecule ASGPR Ligands, Pharmacokinetics, Pharmacodynamics, Endocytosis, Protein Pathogenesis, Drug Development, RA Capital Management | Expanded Human Proteome, Protein Detection Technologies, Therapeutic Potential, Novel Proteins, Connectivity And Functionality Of Proteins, Health And Disease Roles, Therapeutics Discovery, ProFoundry Platform, Biotechnology Innovation, Flagship Labs, Flagship Pioneering, Protein Research, Disease Biology, Medicinal Biochemistry |
| Website | ||
| Website | avilar-tx.com | profoundtx.com |
About Avilar Therapeutics
Avilar Therapeutics, founded in 2020 and based in Waltham, MA, is a pioneering company in the Biotechnology and Pharmaceutical industries. Their slogan, "Pioneering the discovery and development of extracellular protein degraders," succinctly captures their innovative focus on targeted protein degra...
About ProFound Therapeutics
ProFound Therapeutics is at the forefront of biotechnological innovation, driven by its mission to redefine the human proteome and develop a suite of novel medicines. Using its groundbreaking ProFoundry Platform, the company identifies and analyzes a vast array of proteins, shedding light on untappe...
We will tell you when either one moves
BounceWatch watches Avilar Therapeutics and ProFound Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Avilar Therapeutics and ProFound Therapeutics — by email.
Frequently Asked Questions
Compare Avilar Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Avilar Therapeutics on 9 Jun 2026, and ProFound Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
